Eric M. Dube, Chief Executive Officer of Travere Therapeutics, Inc. (TVTX), reported the sale of 128,065 shares of the company's stock on October 19, 2026. The transactions were executed at an average price of $52.97 per share, resulting in a total value of approximately $6.78 million.
This marks a significant disposition of shares by the CEO. While insider sales can occur for various reasons such as portfolio diversification, tax planning, or adherence to pre-arranged trading plans, they are sometimes viewed by the market as an indicator of an insider's current sentiment toward the company's stock.
The reported sale by Mr. Dube follows other recent insider selling activity at Travere Therapeutics. Earlier in October, Mr. Dube also engaged in multiple sales of TVTX shares. Peter Heerma, another executive at the company, also sold shares in September.